SCHEMBL23452060

SCHEMBL23452060

COC(=O)c1cc(=O)n(Cc2ccccc2)c2cc(-c3ccc(OC)cc3)sc12

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KDM4E B2RXH2 2/20 0.49
▸ SMN1; SMN2 Q16637 2/20 0.49
▸ KMT2A Q03164 2/20 0.49
▸ PTGES O14684 1/20 0.47
▸ ERCC5 P28715 1/20 0.47
▸ FEN1 P39748 1/20 0.47
▸ MAPK8 P45983 2/20 0.46
▸ ALDH1A1 P00352 3/20 0.43
▸ TDP1 Q9NUW8 1/20 0.43
▸ HSD17B2 P37059 1/20 0.43
▸ GABRA1 P14867 1/20 0.43
▸ GABRG2 P18507 1/20 0.43
▸ GABRB3 P28472 1/20 0.43
▸ GABRA5 P31644 1/20 0.43
▸ GABRA3 P34903 1/20 0.43
▸ GABRA2 P47869 1/20 0.43
▸ GAA P10253 3/20 0.43
▸ HSD17B10 Q99714 1/20 0.43
▸ MAPT P10636 4/20 0.42
▸ THRB P10828 2/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23452102 0.92 FEN1 (0.51) KDM4ESMN1; SMN2KMT2APTGESERCC5
SCHEMBL23451952 0.91 FEN1 (0.48) KDM4ESMN1; SMN2KMT2APTGESERCC5
SCHEMBL23452125 0.89 LMNA (0.49) KDM4ESMN1; SMN2KMT2APTGESERCC5
SCHEMBL23452156 0.88 KMT2A (0.48) KDM4ESMN1; SMN2KMT2APTGESMAPK8
SCHEMBL23451957 0.82 GABRG2 (0.46) KDM4ESMN1; SMN2KMT2AALDH1A1GABRA1
SCHEMBL23452113 0.78 ALDH1A1 (0.44) KDM4ESMN1; SMN2KMT2AALDH1A1TDP1
SCHEMBL23452066 0.77 ALDH1A1 (0.53) KDM4ESMN1; SMN2KMT2AALDH1A1GABRA1
SCHEMBL23452094 0.75 NPC1 (0.40) KDM4ESMN1; SMN2KMT2APTGESALDH1A1
SCHEMBL23452111 0.74 IKBKB (0.47) SMN1; SMN2KMT2AALDH1A1HSD17B2GABRA1
SCHEMBL23452001 0.71 LMNA (0.43) KDM4ESMN1; SMN2KMT2AALDH1A1GAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11306103-B2 Thieno[3,2-b]pyridine-5(4H)-one derivative compound, preparation method thereof and use thereof KOREA INSTITUTE OF OCEAN SCIENCE & TECHNOLOGY 2022-04-19 — — US disclosed
US-11306103-B2 Thieno[3,2-b]pyridine-5(4H)-one derivative compound, preparation method thereof and use thereof KOREA INSTITUTE OF OCEAN SCIENCE & TECHNOLOGY 2022-04-19 — — US disclosed
US-20210171539-A1 NOVEL THIENO[3,2-B]PYRIDINE-5(4H)-ONE DERIVATIVE COMPOUND, PREPARATION METHOD THEREOF AND USE THEREOF KOREA INSTITUTE OF OCEAN SCIENCE & TECHNOLOGY (KR) 2021-06-10 — — US disclosed
US-20210171539-A1 NOVEL THIENO[3,2-B]PYRIDINE-5(4H)-ONE DERIVATIVE COMPOUND, PREPARATION METHOD THEREOF AND USE THEREOF KOREA INSTITUTE OF OCEAN SCIENCE & TECHNOLOGY (KR) 2021-06-10 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210171539-A1 NOVEL THIENO[3,2-B]PYRIDINE-5(4H)-ONE DERIVATIVE COMPOUND, PREPARATION METHOD THEREOF AND USE THEREOF BRD4, BRPF3, AFF4 KDM4E 125/4885SMN1; SMN2 4333/4885KMT2A 523/4885
US-11306103-B2 Thieno[3,2-b]pyridine-5(4H)-one derivative compound, preparation method thereof and use thereof BRD4, BRPF3, AFF4 KDM4E 159/4885SMN1; SMN2 4244/4885KMT2A 523/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback